Finoriq insights
Apnimed, Inc. (APMD) Historical Metrics
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral. Review APMD fundamentals, ratios, and historical filing metrics on Finoriq.
Company Snapshot
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
- Company
- Apnimed, Inc. (APMD)
- Ticker
- APMD
- Market Cap
- $1.1B
- Latest Price
- $29.98
- Industry
- Biotech & Pharma
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.